Recombinant Human Interferon γ/IFNG Protein

Recombinant Human Interferon gamma is produced by our Mammalian expression system and the target gene encoding Gln24-Gln166 is expressed.

The Recombinant Human Interferon γ/IFNG Protein is a highly purified and biologically active protein that is produced through recombinant DNA technology. This protein is a type of cytokine that plays a crucial role in the immune system's response to viral and bacterial infections, as well as in the regulation of cell growth and differentiation.

The Recombinant Human Interferon γ/IFNG Protein is a potent immunomodulatory agent that has been extensively studied for its therapeutic potential in a variety of diseases, including cancer, viral infections, and autoimmune disorders. It has been shown to have antiviral, antiproliferative, and immunomodulatory effects, making it a promising candidate for the treatment of a wide range of diseases.

This protein is produced using a highly advanced and sophisticated manufacturing process that ensures its purity, potency, and consistency. It is available in a variety of formulations, including lyophilized powder and liquid solutions, and can be used for both in vitro and in vivo applications.

The Recombinant Human Interferon γ/IFNG Protein is a valuable tool for researchers and clinicians who are working to develop new treatments for a variety of diseases. Its unique properties make it an ideal candidate for use in a wide range of applications, including cancer immunotherapy, antiviral therapy, and the treatment of autoimmune disorders.

Overall, the Recombinant Human Interferon γ/IFNG Protein is a highly effective and versatile protein that has the potential to revolutionize the treatment of a wide range of diseases. Its purity, potency, and consistency make it an ideal choice for researchers and clinicians who are looking for a reliable and effective tool for their work.